Yahoo · Nov 13, 2026
GSK (LSE:GSK) Settles Key Vaccine Patent Case And Wins Broad Europe Injunction
GSK (LSE:GSK) reached a cross-licensing agreement with Moderna resolving their COVID-19 vaccine patent dispute in Europe. The pharma group secured a significant injunction against Pfizer-BioNTech covering liposome delivery technology used in RNA vaccines across multiple European markets. Ongoing legal actions and expected appeals around this RNA and liposome IP framework now shape how the largest vaccine makers operate in Europe. This combination of a Moderna settlement and a broad...


